Cancer Research

Imagine a silent epidemic affecting thousands of men each year, often undetected until it’s too late, with societal norms discouraging open conversations about personal health challenges, and prostate cancer standing as the most common cancer among men in the UK, with around 55,000 new cases

In a remarkable advancement that could alter the landscape of cancer care, researchers from University College London (UCL) and the University of Oxford have developed LungVax, the world’s first experimental vaccine aimed at preventing lung cancer. This pioneering initiative, now entering clinical

Imagine a scenario where a patient diagnosed with metastatic colorectal cancer (CRC) receives a treatment that not only halts the disease's progression but also leads to remarkable tumor shrinkage, offering a renewed chance at life. This isn’t just a hopeful vision but a reality for a small subset

The landscape of oncology treatment is witnessing a transformative shift with Johnson & Johnson (J&J) securing a positive recommendation from the UK’s National Institute for Health and Care Excellence (NICE) for its groundbreaking therapy, TALVEY (talquetamab). This approval for use within the

The alarming statistic that individuals with type 1 diabetes face a 4.29-fold increased risk of developing bladder cancer has sent ripples through the medical community, challenging long-held assumptions about the intersection of metabolic disorders and malignancies. With bladder cancer already

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert whose pioneering work in technology and innovation has pushed boundaries in medical research and development. With a deep focus on cutting-edge solutions, Ivan has been at the forefront of exploring focused ultrasound as a